Future of cutting edge research
EVis Bioscience is an ETH spin-off developing a next-generation non-viral vector for targeted gene therapy.
An alternative approach to treating genetic disorders
EVis Bioscience develops innovative gene delivery systems for targeted and personalized medicine.
This includes extracellular vesicles, synthetic lipid nanoparticles, and their hybrids.
Gene delivery
Novel opportunities to deliver small and large nucleic acids.
Gene therapy
New frontiers for a targeted, personalized medicine.
Vehicle sublicenses
We offer hybrid technology to pharma partners for gene-based therapeutics.
Latest posts
Supported by
Partner with Us
We develop our drug product and support pharmaceutical partners by providing our hybrid technology to enable innovative gene therapies for patients.
JOIN THE INNOVATION
We develop our drug product and support pharmaceutical partners by providing our hybrid technology to enable innovative gene therapies for patients.